SK Hynix’s record $26.5 billion IPO and a 4% Nvidia surge drove equities higher, but oil price whipsaws after Iran attacks injected caution just as earnings season begins. The cross-currents set up a pivotal stretch for investors weighing AI valuations against geopolitical risk and the Delta demand signal.
Technology stocks outperformed in a bifurcated market as SK Hynix’s Wall Street debut and buy-the-dip activity drove a 1.74% Nasdaq gain. Meanwhile, a geopolitical shock sent oil above $76/barrel and the 10-year yield toward 4.60%, punishing small caps.
The Dow Jones Industrial Average briefly plummeted 800 points and the S&P 500 fell as much as 1.1% after President Trump declared the Iran ceasefire over. Markets partially recovered after Trump clarified no return to full-scale war, but the episode rattled investor confidence and reignited inflation fears.
Eos Energy’s shares dropped 6.32% to $4.74 on July 7, accompanied by trading volume of 54.4 million—nearly 2x the 3-month average. The decline came despite positive project news and aligns with a sell-off across energy storage peers, with Fluence down 9.1% and Stem down 7.8%.
The Nasdaq tumbled 1.16% and the PHLX Semiconductor Index plunged 4.65% as Samsung’s earnings failed to impress overbought investors, triggering a rotation out of AI chip stocks. With Micron down 4.7% and Sandisk off 7.3%, the selloff raises fresh questions about stretched valuations. Upcoming SK Hynix listing will test whether global demand for AI hardware shares has peaked.
U.S. stocks sold off Tuesday as the Nasdaq tumbled 1.16% while the Dow edged down just 0.25%. The session highlighted a sharp rotation out of megacap technology into traditional industrial and financial names, raising questions about the durability of the bull market.
A trio of biotech stocks generated staggering H1 2026 returns, with Revolution Medicines leading at +230%. Axsome Therapeutics' revenue more than doubled to $617.1 million, underscoring a market rotation into catalyst-driven, high-growth healthcare plays amid macro uncertainty.
AI semiconductor stocks staged a powerful rebound on July 6, with Broadcom up 5.3% and Micron +4.2%, ahead of SK Hynix’s $28 billion Nasdaq IPO. TeraWulf soared 16.9% on a $19 billion data center deal with Anthropic, highlighting the capital intensity and volatility driving the AI trade.
Nvidia's forward P/E has collapsed to 21.7, in line with the S&P 500, while Meta's $70B+ capex narrative obscures accelerating ad revenue. This deep-value setup in AI leaders could spark a sharp re-rating as H2 earnings season kicks off.
With the S&P 500 yielding only 1.25%, savvy income investors are turning to stocks like AT&T (4.8% yield) and Coca-Cola (64 consecutive years of dividend increases). Allocating $3,000 across these names can generate dependable quarterly income while offering capital appreciation potential.
The Roundhill Magnificent Seven ETF has rocketed 163% since its 2023 launch, powered by Nvidia’s 16,930% decade gain. For finance pros, the equal-weight structure offers concentrated AI exposure with sharp drawdowns, raising the stakes on portfolio allocation.
As US big tech wobbles, European investors seeking AI exposure are rotating into power suppliers and banks, capitalizing on massive EU and German fiscal packages. Prysmian surged 150% and ABB 84% on infrastructure demand, while the Stoxx 600’s minuscule 9% tech weighting forces creative ‘pick and shovel’ trades.
Despite nearly 66% of S&P 500 stocks climbing, the index posted its second losing week in 13 as heavy selling in AI megacaps like Micron completely negated the broad market rally. Oil prices dropped to pre-Iran crisis levels, boosting transportation and healthcare stocks, while Eli Lilly soared 7.1% on European drug approvals.
With a 6.9% yield (vs 1% for the S&P 500) and a 130% payout ratio, Pfizer presents a classic risk-reward scenario for income portfolios. The stock’s 60% decline from 2021 highs prices in significant pessimism, but historical resilience may offer patient investors a favorable entry.
Amid mounting recession fears and near-record index levels, an investor outlines a hold-through-any-downturn thesis for Medtronic (3.5% yield, 49-year dividend growth) and Realty Income (5.2% yield, 31-year streak). The strategy highlights income stability as a hedge against equity volatility.
A sharp tech sell-off dragged the Nasdaq to a 5% weekly loss on June 26, led by a 10%+ plunge in Sandisk and a 7% drop in Micron. Inflation fears and Jeremy Grantham's market bubble warning fueled a rotation to gold and bonds.
A sharp reversal in overheated AI stocks dragged the S&P 500 down 1.4% and the Nasdaq down 2.2% on Tuesday, as global markets priced in rising odds of a Fed rate hike. The Kospi plunged 10%, and chipmakers Micron and Nvidia were among the biggest losers.
The S&P 500 and Nasdaq ended lower on Monday, dragged by a 5% slump in Alphabet amid AI infrastructure spending concerns, while the Dow eked out gains. SpaceX plunged 16.4% after its debt offering, and oil prices fell on progress in US-Iran talks.
RBC Wealth Management’s mid-year outlook highlights a resilient U.S. market, with IT sector profits soaring 49% year-over-year in Q1 2026, fueling an S&P 500 rally despite rate and election risks. Disciplined investors are being rewarded, but a historical average 21% midterm correction looms.
Micron Technology's quarterly results will gauge whether AI-fueled chip demand can sustain the stock market rally. With shares up 298% YTD, the report is a litmus test for semiconductor valuations and tech investor sentiment.